Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 12
Submit an article Journal homepage
105
Views
4
CrossRef citations to date
0
Altmetric
Letter

Radioimmunotherapy with 90Y-ibritumomab tiuxetan for a hemodialysis patient with relapsed follicular lymphoma

Kenji FukunoDepartment of Hematology, Gifu Municipal Hospital, Gifu, Japan
,
Hisashi TsurumiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, JapanCorrespondence[email protected]
,
Toshiki YamadaDepartment of Hematology, Gifu Prefectural General Medical Center, Gifu, Japan
,
Takayoshi IidaDepartment of Radiology, Gifu Municipal Hospital, Gifu, Japan
,
Takeshi TakahashiDepartment of Hematology, Gifu Municipal Hospital, Gifu, Japan
&
Hisataka MoriwakiFirst Department of Internal Medicine, Gifu University Graduate School of Medicine, Gifu, Japan
Pages 2731-2733 | Received 21 Feb 2013, Accepted 03 Mar 2013, Published online: 17 Apr 2013

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nelson Leung & Thomas E. Witzig. (2013) The use of 90yttrium-ibritumomab tiuxetan in patients on dialysis: what do we know regarding its pharmacokinetics?. Leukemia & Lymphoma 54:12, pages 2586-2587.
Read now

Articles from other publishers (3)

Hajime Yasuda, Mutsuko Yasuda & Norio Komatsu. (2021) Chemotherapy for non‐Hodgkin lymphoma in the hemodialysis patient: A comprehensive review. Cancer Science 112:7, pages 2607-2624.
Crossref
Mahsa Eskian, MirHojjat Khorasanizadeh, Francoise Kraeber-Bodere & Nima Rezaei. (2016) Radioimmunotherapy in non-Hodgkin lymphoma: Prediction and assessment of response. Critical Reviews in Oncology/Hematology 107, pages 182-189.
Crossref
. (2014) Ibritumomab tiuxetan Y 90/rituximab. Reactions Weekly 1501:1, pages 24-24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.